| A. Menarini GmbH - Ranexa 375 mg, Retardtabletten | | 60533 | | 01 | | Ranexa 375 mg | | Retardtabletten | | C01EB18 | | Ranolazine | | 13.04.2010 | | |
| | Composition | | ranolazinum 375 mg, cellulosum microcristallinum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, hypromellosum, magnesii stearas, natrii hydroxidum corresp. natrium 1.15 mg, Überzug: hypromellosum, macrogolum 400, polysorbatum 80, cera carnauba, E 171, E 132, pro compresso obducto. | | Packungsbestandteile | | Comprimés retards | | | | | Principe actif | Concentr. |
|---|
| Ranolazinum | 375 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Ranolazinum | 375 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acidi Methacrylici | | | | Cellulosum Microcristallinum | | | | Cera Carnauba | | | | E 132 | | color. | | E 171 | | color. | | Hypromellosum | | Überzug | | Macrogol | 400 | | | Magnesii Stearas | | | | Methylis Methacrylatis Polymerisatum | | | | Sodium Hydroxide | | | | Polysorbatum 80 | | | | Pro Compresso Obducto | | |
| |
| |
|
